The arrival of Retatrutide in the UK is creating significant excitement within the weight loss community. This novel dual medication – targeting both GLP-1 and GIP – offers a significantly new solution to tackling weight challenges. Until recently, options have been constrained for many, and Retatrutide embodies a encouraging prospect for patie